All terms in NCIT
| Label | Id | Description |
|---|---|---|
| System, LOINC Axis 4 | NCIT_C40568 | [The physical environment (milieu, context) within which an observation is made. For example, the system in which a sodium concentration is measured could be a urine sample, serum sample, or a plasma sample.] |
| Method, LOINC Axis 6 | NCIT_C40570 | [The process by which an observation value was obtained. Example methods include: weighing, use of a mass spectrometer, use of an ion sensitive electrode, and examination using a microscope.] |
| REL Gene Amplification | NCIT_C40571 | |
| Oncogene Deregulation | NCIT_C36344 | |
| Gene Amplification Abnormality | NCIT_C45581 | [An increase in the copy number of a particular gene. This type of abnormality can be either inherited or somatic.] |
| REL Gene | NCIT_C17084 | [This gene is involved in transcriptional regulation and signal transduction through the nuclear factor kappa B NFKB signal transduction pathway.] |
| Merkel Cell Carcinoma pM1c TNM Finding v7 | NCIT_C88536 | [Merkel cell carcinoma with metastasis to all other visceral sites. (from AJCC 7th Ed.)] |
| Merkel Cell Carcinoma pM1 TNM Finding v7 | NCIT_C88533 | [Merkel cell carcinoma with metastasis beyond regional lymph nodes. (from AJCC 7th Ed.)] |
| Nephrogenic Rest | NCIT_C88537 | [Remnants of nephrogenic blastema cells in the kidney following embryonic development.] |
| Perilobar Nephrogenic Rest | NCIT_C88538 | [A nephrogenic rest found at the periphery of the renal lobe.] |
| Merkel Cell Carcinoma Clinical TNM Finding v7 | NCIT_C88539 | [A clinical finding about one or more characteristics of Merkel cell carcinoma, following the rules of the TNM AJCC v7 classification system. TNM clinical findings are based on clinical inspection and palpation of the involved area and the regional lymph nodes and/or radiologic studies. The TNM clinical and pathologic primary tumor classifications of Merkel cell carcinoma are the same. (from AJCC 7th Ed.)] |
| Merkel Cell Carcinoma TNM Finding v7 | NCIT_C88497 | [A finding about one or more characteristics of Merkel cell carcinoma, following the rules of the TNM AJCC v7 classification system. (from AJCC 7th Ed.)] |
| Merkel Cell Carcinoma Pathologic Distant Metastasis TNM Finding v7 | NCIT_C88532 | [A pathologic finding about one or more characteristics of Merkel cell carcinoma, following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases. (from AJCC 7th Ed.)] |
| Merkel Cell Carcinoma Pathologic TNM Finding v7 | NCIT_C88498 | [A pathologic finding about one or more characteristics of Merkel cell carcinoma, following the rules of the TNM AJCC v7 classification system. TNM pathologic findings are based on the histologic examination of the regional lymph nodes following focused (sentinel lymph node biopsy), therapeutic, or complete lymphadenectomy. (from AJCC 7th Ed.)] |
| Merkel Cell Carcinoma pM1a TNM Finding v7 | NCIT_C88534 | [Merkel cell carcinoma with metastasis to skin, subcutaneous tissues or distant lymph nodes. (from AJCC 7th Ed.)] |
| Merkel Cell Carcinoma pM1b TNM Finding v7 | NCIT_C88535 | [Merkel cell carcinoma with metastasis to lung. (from AJCC 7th Ed.)] |
| Negative Regulation of Antibody Titer | NCIT_C40594 | [Any physiologic response which results in a reduced number of active antibodies circulating in the plasma. This process is involved in limiting the persistence of circulating antibodies and in maintaining an active antibody repertoire against recently exposed antigens.] |
| Regulation of Antibody Titer Process | NCIT_C40583 | [Any physiologic response that results in an increased number of active antibodies circulating in the plasma. This process is involved in tuning the antibody response to recently exposed antigens.] |
| Negative Regulation of Complement Activation | NCIT_C40595 | [Any physiologic process in which the C3 and C5 convertases are disassembled or proteolytically inactivated, limiting the persistence of convertase activity. This process is involved in regulating the extent of action of the complement system.] |
| Cytokine Suppression | NCIT_C40596 | [Any therapeutic or preventive precedure that involves inhibition of the production or activity of a cytokine, and results in the inhibition of the mature function of immune cells. Cytokine suppression is intended to favorably modulate functions of the immune system.] |